• Loading...

    Corporate Patrons

    If you are interested in participating in the RPA Corporate Patrons Program, please contact Dale Singer 301-468-3515 ext. 11 or dsinger@renalmd.org. For information on RPA's standards for the program, click here. We appreciate your interest.

    RPA is pleased to have the following companies as Corporate Patrons.

North Chicago, IL

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries.

Akebia Therapeutics, Inc.
Cambridge, MA

Akebia Therapeutics, Inc. is a biopharmaceutical company focused on delivering innovative therapies to patients with chronic kidney disease (CKD) through hypoxia-inducible factor (HIF) biology. Akebia has commenced Phase 3 development of its lead product candidate, vadadustat (formerly AKB-6548), an oral therapy for the treatment of anemia related to CKD.


American Regent, Inc.
Shirley, NY

American Regent, Inc., manufactures of Venofer® (iron sucrose injection, USP). American Regent’s quality services to the renal community include a clinical support team of nephrology specialists, a professional Speakers Bureau, patient education materials, regional Iron and Anemia Workshops, and a Venofer® Patient Assistance Program and Reimbursement Hotline.

American Renal Associates
Beverly, MA

American Renal Associates is a national provider of dialysis services, focused exclusively on the partnership model with nephrologists. ARA believes that the dialysis clinic is, in many ways, a natural extension of the nephrology practice. As an owner the Nephrologist has complete autonomy in treating patients and is empowered to ensure high quality care.

Amgen, Inc.
Thousand Oaks, CA

Amgen develops and delivers important, cost-effective therapeutics based on advances in cellular and molecular biology. For more than 25 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.


Wilmington, DE

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca-us.com

AtCor Medical Inc.
Itasca, IL

AtCor Medical develops, manufactures and markets SphygmoCor systems, which are the worldwide gold standard for non-invasive assessment of central aortic blood pressure, arterial stiffness, pulse wave analysis and pulse wave velocity. The company also offers leading edge clinical trials management services within our blood pressure core lab.

Bard Peripheral Vascular
Tempe, AZ

As a leader in the peripheral vascular industry, Bard Peripheral Vascular takes pride in fulfilling the clinical needs of our customers and patients. From C. R. Bard’s first arterial prosthesis developed in 1954, Bard and the division of Bard Peripheral Vascular have demonstrated commitment to innovative medical technology by introducing surgical and interventional devices for peripheral vascular patency, while providing exceptional service and support to surgeons, interventionists and radiologists.  

McGaw Park, IL

Baxter is a leading global manufacturer of a complete and complementary portfolio of dialysis-related products and services designed to assist patients with kidney disease throughout the continuum of their care. For nearly 50 years, Baxter has been at the forefront of innovation in kidney care. In 1956, the company introduced the first disposable coil dialyzer, a development that greatly enhanced the use and application of hemodialysis. Years later, Baxter was the first company to introduce peritoneal dialysis products, and the company continues to support the care of people with kidney disease around the world.

Fresenius Medical Care North America
Waltham, MA

Providing direct renal services to over 167,000 ESRD patients, Fresenius Medical Care is the largest provider of renal therapy services and products in the nation. We manufacture the leading equipment and other dialysis-related supplies including 2008® HD systems, Liberty® and stay·safe® PD systems, and Optiflux® dialyzers. FMCNA is a major supplier of nation’s renal pharmaceuticals offerings.

Genzyme Corporation
Cambridge, MA

Genzyme, a global health care company, delivers innovative biotechnology products and services in therapeutics, surgery and diagnostic areas. Genzyme is the manufacturer of Renagel® (sevelamer hydrochloride) and Hectorol® (doxercalciferol). Genzyme is a leader in health care awareness and education for renal care specialists and patients worldwide.  

Lake Forest, IL

Hospira is the world’s leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars. The company is headquartered in Lake Forest, Ill., and has approximately 17,000 employees.

Keryx Biopharmaceuticals, Inc.
New York, NY

Keryx Biopharmaceuticals, headquartered in New York, is focused on bringing innovative therapies to market for patients with renal disease. 

Lifeline Vascular Access
Vernon Hills, IL

Lifeline Vascular Access develops and manages a nationwide network of dedicated access centers that are committed to delivering improved clinical outcomes and quality of life for patients through optimized vascular access care standards. Lifeline Vascular Access helps reduce missed dialysis treatments and eliminates communication gaps, inconsistent care and long waits for access care while improving patient outcomes and reducing related medical costs.


NxStage Medical, Inc.
Lawrence, MA

NxStage Medical, Inc. is a medical device company that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, acute kidney failure and fluid overload. Our primary product is the NxStage System One, a compact, portable hemodialysis machine cleared by the FDA for use in the home and acute settings. Through our Medisystems brand, we also manufacture and sell needles and blood tubing sets in the acute and chronic settings.


OPKO Renal
Miami, FL

OPKO Renal, a division of OPKO Health, Inc., is committed to developing products that transform the standard of care in nephrology. OPKO develops proprietary products to treat secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). Our lead product, Rayaldee®, is indicated for the treatment of secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease and total blood levels of less than 30 ng/mL 25-hydroxyvitamin D.

Questcor Pharmaceuticals, Inc.
Hayward, CA

Questcor Pharmaceuticals is a biopharmaceutical company whose lead product, HP Acthar® Gel (repository corticotropin injection), is used in a variety of serious conditions. The indications include inducing a diuresis or remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus.

W. L. Gore & Associates
Flagstaff, AZ

Preserving the vascular access site demands regular surgical revision because each case presents a unique challenge. That's why Gore's comprehensive product line covers full graft, jump graft, suture, and stent-graft revision with a variety of configurations. As the experts in ePTFE technology, we are constantly investigating ways to improve outcomes in vascular access.

ZS Pharma
San Mateo, CA

ZS Pharma was founded in 2008, and in December 2015, joined the AstraZeneca Group. ZS is dedicated to challenging the status quo in disease states where therapeutic options have been limited with innovative thinking, unique technology, and new approaches. Additional information is available at www.zspharma.com.